Nutraceutical Prevention of Diabetic Complications-Focus on Dicarbonyl and Oxidative Stress

Mark F McCarty1, James J DiNicolantonio2, James H O'Keefe2

  • 1Catalytic Longevity Foundation, San Diego, CA 92109, USA.

Insights

Diabetic complications stem from oxidative and dicarbonyl stress. Strategies targeting methylglyoxal detoxification and oxidative pathways, including Nrf2 activation and zinc, show promise for mitigating these issues.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Endocrinology

Background:

  • Diabetes complications arise from oxidative and dicarbonyl stress due to excess glucose metabolism.
  • Methylglyoxal, a reactive dicarbonyl compound, significantly contributes to diabetic pathology.
  • Effective insulin activity is crucial for regulating glucose metabolism and preventing stress accumulation.

Purpose of the Study:

  • To explore the mechanisms underlying oxidative and dicarbonyl stress in diabetes.
  • To identify key molecular targets and pathways for therapeutic intervention.
  • To evaluate the potential of nutraceuticals and minerals in managing diabetic complications.

Main Methods:

  • Investigated the role of methylglyoxal detoxification pathways, particularly the glyoxalase system.
  • Examined the regulation of glyoxalase I transcription by Nrf2 and zinc-mediated pathways.
  • Reviewed the impact of various compounds and interventions on oxidative stress markers and diabetic complications.

Main Results:

  • Glyoxalase I, rate-limiting for methylglyoxal detoxification, is upregulated by Nrf2 activators (lipoic acid, sulforaphane, glycine) and zinc.
  • Zinc promotes glyoxalase I and metallothionein transcription, potentially explaining its protective effects.
  • Multiple strategies targeting oxidative stress, including mitophagy, UCP2 induction, and Nrf2 activation, are proposed.

Conclusions:

  • Targeting methylglyoxal metabolism via glyoxalase I induction is a promising therapeutic strategy for diabetic complications.
  • Nutraceuticals and minerals like zinc, acting through pathways like Nrf2, can mitigate diabetic stress.
  • A multi-pronged approach addressing both dicarbonyl and oxidative stress is essential for managing diabetes complications.

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
340
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
47
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.7K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
663
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
25